These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6181414

  • 21. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.
    Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J.
    Drug Alcohol Depend; 2007 Dec 01; 91(2-3):187-94. PubMed ID: 17624687
    [Abstract] [Full Text] [Related]

  • 24. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.
    Pharmacopsychiatry; 2002 Sep 01; 35(5):159-64. PubMed ID: 12237786
    [Abstract] [Full Text] [Related]

  • 25. [Buprenorphine in the treatment of opiate dependence].
    Auriacombe M, O'Brien CP, Tignol J.
    Ann Med Interne (Paris); 1994 Nov 01; 145 Suppl 3():27. PubMed ID: 7880009
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR, Cabansag SR, France CP.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):574-84. PubMed ID: 9262317
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys.
    Mello NK, Lukas SE, Bree MP, Mendelson JH.
    Drug Alcohol Depend; 1988 May 01; 21(2):81-97. PubMed ID: 3416736
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE.
    Exp Clin Psychopharmacol; 2005 Nov 01; 13(4):293-302. PubMed ID: 16366759
    [Abstract] [Full Text] [Related]

  • 39. Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.
    France CP, Jacobson AE, Woods JH.
    J Pharmacol Exp Ther; 1984 Sep 01; 230(3):652-7. PubMed ID: 6206224
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.